WHO ICTRP trial
A Study of LY3209590 Compared to Degludec in Adults With Type 2 Diabetes Who Are…
JPRN-jRCT2031220290 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2031220290 |
|---|---|
| Public title | A Study of LY3209590 Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time |
| Scientific title | A Phase 3, Parallel-Design, Open-Label, Randomized Control Study to Evaluate the Efficacy and Safety of LY3209590 as a Weekly Basal Insulin Compared to Insulin Degludec in Insulin Naive Adults With Type 2 Diabetes - I8H-MC-BDCX |
| Primary sponsor | Masaki Takeshi |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 3 |
| Countries | Brazil;Japan;Canada;Japan;China;Japan;Czechia;Japan;Germany;Japan;Greece;Japan;Korea, Republic of;Japan;Mexico;Japan;Puerto Rico;Japan;United States;Japan |
| Conditions | Diabetes,Type 2 Diabetes |
| Interventions | -Drug: LY3209590 Administered SC -Drug: Insulin Degludec Administered SC Study Arms -Experimental: LY3209590 Participants will receive LY3209590 subcutaneously (SC) once weekly. Intervention: Drug: LY3209590 -Active Comparator: Insulin… |
| Registration date | Aug 26, 2022 |
| Target size | 912 |
| Secondary IDs | NCT05362058 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: